Quick Answer
Bionano Genomics, Inc. reported Stockholders Equity of $44.42 million for fiscal year 2025.
Bionano Genomics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $44.42M | +25.6% |
| 2024 | $35.38M | -63.2% |
| 2023 | $96.16M | -61.4% |
| 2022 | $249.40M | -26.0% |
| 2021 | $337.12M | +860.9% |
| 2020 | $35.08M | +871.0% |
| 2019 | $3.61M | -64.4% |
| 2018 | $10.14M | +120.2% |
| 2017 | -$50.23M | -84.3% |
| 2016 | -$27.26M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $49.80M | +1.9% | +9.8% |
| June 30, 2025 | $45.37M | -43.5% | -5.8% |
| March 31, 2025 | $48.19M | -41.8% | +36.2% |
| December 31, 2024 | $35.38M | -63.2% | -27.6% |
| September 30, 2024 | $48.86M | -58.9% | -39.2% |
| June 30, 2024 | $80.33M | -62.6% | -2.9% |
| March 31, 2024 | $82.77M | -64.2% | -13.9% |
| December 31, 2023 | $96.16M | -61.4% | -19.2% |
- Bionano Genomics, Inc. showed an increase of +25.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Bionano Genomics, Inc.’s stockholders equity has grown by 263.0% (from -$27.26 million to $44.42 million).
- The most recent figure is from Bionano Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: